Ms Brown's daughter, Megan Johnson, 29, said a drug treatment called Phesgo had changed her mum's life and allowed her to ...

Corcept Therapeutics said on Monday its experimental drug in combination with chemotherapy helped delay progression of a type ...

The European Commission on Friday approved AstraZeneca Plc (NASDAQ:AZN) and Daiichi Sankyo's (OTC:DSKNY) Enhertu (trastuzumab ...

Some commonly prescribed photosensitizing drugs increase skin cancer risk, according to a study published online March 18 in ...

Seth Wander, MD, PhD, discusses the tolerability of selective estrogen receptor degraders and next-generation anti-estrogen ...

Evolution in women's cancer diagnostics: from histopathology to molecular testing, personalized treatment for breast, ovarian ...

Hormone therapy for prostate cancer is aimed at reducing or eliminating ... and chemotherapy — usually docetaxel, she says. "The drugs approved to be added to ADT have all been shown in large ...

HealthDay News — Some commonly prescribed photosensitizing drugs increase skin cancer risk, according to a study published online March 18 in Photodermatology, Photoimmunology & Photomedicine.

The U.S Food & Drug Administration has granted approval for a targeted therapy called CABOMETYX ® to treat pancreatic ...

Breakthrough study uses chromosome physical properties to monitor breast cancer therapy outcomes and predict recurrence ...

C, provided insights on what to consider when treating patients with HR+, HER2- breast cancer in the second line of treatment.

and colleagues assessed whether the use of commonly prescribed photosensitizing drugs increases skin cancer risk. The researchers found that hormone replacement therapy significantly increased the ...